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Abstract
Background: Exposure to air pollution is an important risk factor for cardiovascular morbidity
and mortality, and is associated with increased blood pressure, reduced heart rate variability,
endothelial dysfunction and myocardial ischaemia. Our objectives were to assess the cardiovascular
effects of reducing air pollution exposure by wearing a facemask.
Methods: In an open-label cross-over randomised controlled trial, 15 healthy volunteers (median
age 28 years) walked on a predefined city centre route in Beijing in the presence and absence of a
highly efficient facemask. Personal exposure to ambient air pollution and exercise was assessed
continuously using portable real-time monitors and global positional system tracking respectively.
Cardiovascular effects were assessed by continuous 12-lead electrocardiographic and ambulatory
blood pressure monitoring.
Results: Ambient exposure (PM2.5 86 ± 61 vs 140 ± 113 μg/m3; particle number 2.4 ± 0.4 vs 2.3 ±
0.4 × 104 particles/cm3), temperature (29 ± 1 vs 28 ± 3°C) and relative humidity (63 ± 10 vs 64 ±
19%) were similar (P > 0.05 for all) on both study days. During the 2-hour city walk, systolic blood
pressure was lower (114 ± 10 vs 121 ± 11 mmHg, P < 0.01) when subjects wore a facemask,
although heart rate was similar (91 ± 11 vs 88 ± 11/min; P > 0.05). Over the 24-hour period heart
rate variability increased (SDNN 65.6 ± 11.5 vs 61.2 ± 11.4 ms, P < 0.05; LF-power 919 ± 352 vs
816 ± 340 ms2, P < 0.05) when subjects wore the facemask.
Conclusion: Wearing a facemask appears to abrogate the adverse effects of air pollution on blood
pressure and heart rate variability. This simple intervention has the potential to protect susceptible
individuals and prevent cardiovascular events in cities with high concentrations of ambient air
pollution.
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Introduction
Air pollution, and especially traffic-derived particulate
matter [1], is now established as a major cause of cardi-
orespiratory morbidity and mortality [2-4]. Epidemiolog-
ical studies have shown that chronic air pollution
exposure is associated with the degree of atherosclerosis
[5,6], and the risk of cardiovascular events [7]. Acute expo-
sure causes exacerbation of existing cardiorespiratory con-
ditions leading to an increase in hospital admissions [8]
and deaths [9].
The mechanisms of these associations are unclear but
recent controlled exposure studies have demonstrated
that air pollution causes vascular endothelial dysfunction
[10], arterial vasoconstriction [11], increased blood pres-
sure [12] and myocardial ischaemia [13]. Observational
studies have also suggested that air pollution exposure
impairs regulation of the autonomic nervous system and
reduces heart rate variability [14,15]. A combination of
these effects is likely to account for the increase in cardio-
vascular events seen following exposure to air pollution.
There is therefore a need to consider approaches that can
reduce ambient air pollution exposure on both a personal
and societal level.
In Beijing China, particulate matter (particle diameter <
10 μm; PM10) air pollution averages around 150 μg/m3
and, in 2006, levels exceeded the World Health Organisa-
tion recommended national standards
(PM10concentration < 50 μg/m3) on 241 out of 365 days
[16]. Despite considerable efforts to improve air quality,
pollution remains the single largest environmental and
public health issue affecting Beijing. The extensive use of
coal and the growing number of motor vehicles (esti-
mated 3.3 million vehicles on the roads in August 2008)
have contributed to air pollution. In addition, the city's
geographical location exacerbates the problem with the
surrounding mountain ranges impeding air circulation
and dispersion of pollutants.
Increasing concern relating to the health effects of air pol-
lution has led many individuals to use facemasks to
reduce personal exposure. The efficiency of these masks
and the potential cardiovascular benefits on people
exposed to urban air pollution has yet to be established.
The aims of this study were to assess the efficacy of face-
masks in removing potentially hazardous particulate air
pollution and to determine the potential cardiovascular
benefits of a simple facemask in a polluted urban environ-
ment.
Methods
Subjects
Fifteen healthy volunteers were recruited from the Fuwai
Hospital, Beijing in August 2008. All subjects were non-
smokers, received no regular medication, and had no
intercurrent illnesses. All subjects gave their written con-
sent to participate in the study, which was reviewed and
approved by the local ethics committee, in accordance
with the Declaration of Helsinki.
Assessment of mask efficacy
Masks designed for use by cyclists, pedestrians and occu-
pational settings were tested for penetrance of fresh diesel
exhaust particulate. Diesel engine exhaust was generated
from the idling (1500 rpm) engine (F3M2011, Deutz Ag,
Köln, Germany) of a 35 KVA generator (Bredenoord,
Apeldoorn, Netherlands). The exhaust was diluted with
filtered air to obtain a mass concentration of 75 ± 12 μg/
m3 (as measured by gravimetric analysis) and a particle
number concentration of 500,000 particles/cm3 (conden-
sation particle counter [CPC] model 3022, TSI Instru-
ments, High Wycombe, UK). Sections of each mask filter
were mounted in a filter holder. After 5 min of baseline
measurements, filters were introduced between the
exhaust and the CPC that sampled at a flow rate of 1.5 L/
min. Particle number was recorded for 5 min and pene-
trance defined as the percentage of particles passing
through the filter compared to baseline.
Study design
All 15 subjects attended the Fuwai Hospital on two occa-
sions, each at least one week apart, during August 2008. In
a randomised open-label controlled cross-over study, sub-
jects were randomised to wear no mask or a highly effi-
cient facemask filter (Dust Respirator 8812, 3 M, St Paul
USA). When randomised to wear the facemask, subjects
were asked to wear the mask for 24 hours prior to the
study day and 24 hours of the study day. Subjects were
asked to wear the mask at all times when outside, and as
much as possible whilst indoors. On the study day, sub-
jects were asked to walk for 2 hours in a city centre loca-
tion (Figure 1) along the inner ring road in Beijing
between 8 and 10 am.
Pollution and activity monitoring
Personal exposure to air pollutants was monitored using
a collection of portable monitoring equipment mounted
in a backpack. Particle mass concentration (particle diam-
eter < 2.5 μm; PM2.5) was measured in using a light-scat-
tering nephelometric method using a DataRAM monitor
(pDR-1500, Thermo Scientific, Franklin, USA). Particle
number was measured using a handheld condensation
particle counter (CPC 3007, TSI Instruments Ltd, High
Wycombe, UK). Ambient temperature and relative
humidity were recorded using a sensor on the outside of
the backpack (Omegaette® HH-314, Omega Engineering
Ltd, Connecticut, USA). Gaseous pollutants were meas-
ured using a multigas analyser (X-am 7000, Dräger Safety,
Pittsburgh, USA) measuring carbon monoxide (CO),Particle and Fibre Toxicology 2009, 6:8 http://www.particleandfibretoxicology.com/content/6/1/8
Page 3 of 9
(page number not for citation purposes)
nitrogen dioxide (NO2) and sulphur dioxide (SO2) using
electrochemical sensors with a sensitivity of 1 part per mil-
lion.
Physical activity was assessed using a portable global posi-
tioning system (GPS) monitor secured to the outside of
the bag (eTrex Summit HC, Garmin, USA). This recorded
the route taken by volunteers, their total distance trav-
elled, and average speed. This information was used,
along with baseline anthropometric measurements, to
calculate the energy expended during the walk in kilocal-
ories and metabolic equivalents (METS).
Holter monitoring
Subjects were fitted with a 12-lead continuous electro-
graphic Holter monitor (Lifecard 12, Spacelabs, UK) at
the beginning of the study day for 24 hours. Holter elec-
trographic traces were analysed using DelMar Reynolds
proprietary software packages by two blinded observers.
The quality of the electrocardiographic trace was manu-
ally inspected before arrhythmias were automatically
detected using the Pathfinder software package. Identified
arrhythmias were then individually inspected, verified or
deleted as appropriate. Average heart rate and heart rate
variability in both time and frequency domains were ana-
lysed using the HRV Tools software package, with identi-
fied arrhythmias excluded from this analysis.
Ambulatory blood pressure
Subjects were fitted with an ambulatory blood pressure
monitor (Model 90217, Spacelabs, UK) at the beginning
of the study day. Blood pressure was recorded at the left
brachial artery every 15 minutes during the 2-hour walk,
every 30 minutes for the rest of the daytime (07:00 to
22:00), and every hour overnight (22:00 – 07:00).
City centre route chosen in central Beijing Figure 1
City centre route chosen in central Beijing. A representative recording from the GPS device contained in the monitoring 
backpack is shown. The walk goes from the Fuwai Hospital (A), along the inner ring road (B) and towards the city centre (C) 
before turning back. Image courtesy of Google™ Earth.Particle and Fibre Toxicology 2009, 6:8 http://www.particleandfibretoxicology.com/content/6/1/8
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Symptom questionnaire
Subjects were asked to complete a symptom question-
naire using a visual analogue scale at the beginning of the
study day, after the 2-hour walk and at the 24-hour visit.
They were asked to record any physical symptoms, as well
as report a perception of the degree of pollution and the
tolerability of the mask.
Data analysis and statistical methods
Subjects were randomised to wearing a mask on their first
or second visit using a random number generator. All data
are expressed as mean (95% confidence interval [CI])
unless otherwise stated. The symptom questionnaire was
based on a visual analogue scale. Scores were converted
into a percentage, and analysed using 2-way analysis of
variance (ANOVA) with repeated measures using time
and the mask intervention as variables. The occurrences of
arrhythmias during the 24-hour monitoring period were
compared using the Wilcoxon matched pairs method. All
other parameters were evaluated using paired Student's t-
tests. Statistical significance was taken at the 5% level. All
data were analysed using GraphPad Prism (Version 4 for
Macintosh, GraphPad Software, San Diego, USA) on a
Macintosh personal computer.
Results
Mask efficiency
Mask penetrance was highly dependent on mask type
(Figure 2). The 3 M Dust Respirator (Model 8812, 3 M, St
Pauls, USA) was selected for the intervention study as it
provided good filtration performance and was extremely
efficient and comfortable to wear.
Table 1: Exposure characteristics during city centre walks.
Without Mask With Mask
PM2.5, μg/m3 86
(52 – 120)
140
(77 – 203)
Particle count, number/cm3 24184
(22061 – 26306)
23379
(21350 – 25409)
CO, number of peaks 6.2
(3.2 – 9.3)
3.3
(1.3 – 5.2)
NO2, number of peaks Nil Nil
SO2, number of peaks Nil Nil
Temperature, °c 29.2
(28.6 – 29.8)
28.1
(26.3 – 29.9)
Relative humidity, % 63
(58 – 68)
64
(53 – 74)
Data expressed as mean (95% confidence interval).
P > 0.05 compared to control (without mask) day for all, Student's 
paired t-test.
Penetrance of commercially available filters: 3 M Dust Respirator 8812, Dust Respirators A and B, Cyclist Masks A to D Figure 2
Penetrance of commercially available filters: 3 M Dust Respirator 8812, Dust Respirators A and B, Cyclist 
Masks A to D. The Teflon filter is an industry standard filter for aerosol studies included as a control. Cotton handkerchiefs 
and surgical masks are often seen worn in public areas in parts of Asia.Particle and Fibre Toxicology 2009, 6:8 http://www.particleandfibretoxicology.com/content/6/1/8
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Intervention study
Fifteen subjects (20–45 years) completed the study. Sub-
jects were predominantly female (13:2) with a mean
height of 164 cm (95% CI, 160 – 167), weight of 55 kg
(95% CI, 50 – 60) and body mass index of 20.5 kg/m2
(95% CI, 19.3 – 21.7). There were no differences (P > 0.05
for all parameters) in ambient pollution exposure during
the 2-hour walk between the two visits (Table 1). Based on
the measured penetrance of 3.4%, assuming a perfect
facial fit and similar flow rates, we predict that the particle
count to which subjects were exposed when wearing a
mask was reduced to just 795 (95% CI, 726 – 864) parti-
cles/cm3.
There were no differences in 24-hour average heart rate or
blood pressure during the two study days (Table 2). Hol-
ter analysis revealed an increased SDNN (65.6 ± 11.5 vs
61.2 ± 11.4 ms, P < 0.05) and LF-power (919 ± 352 vs 816
Table 2: 24-hour ambulatory blood pressure monitoring and Holter analysis for heart rate variability with each visit.
Without Mask With Mask
24 hour SBP, mmHg 106
(100 – 112)
106
(101 – 111)
DBP, mmHg 69
(66 – 73)
70
(67 – 73)
MAP, mmHg 82
(79 – 86)
82
(78 – 86)
Heart rate, bpm 74
(70 – 77)
72
(68 – 76)
Night SBP, mmHg 100
(93 – 107)
101
(95 – 106)
DBP, mmHg 63
(60 – 67)
64
(61 – 67)
MAP, mmHg 76
(73 – 79)
75
(71 – 79)
Heart rate, bpm 64
(61 – 67)
61
(58 – 65)
Day SBP, mmHg 110
(104 – 116)
109
(104 – 114)
DBP, mmHg 73
(69 – 76)
73
(70 – 76)
MAP, mmHg 85
(81 – 88)
85
(81 – 89)
Heart rate, bpm 79
(74 – 84)
78
(73 – 82)
Heart rate variability Data validity, % 95.9 95.0
Average NN interval, ms 829
(789 – 869)
850
(805 – 896)
pNN50, % 15.9
(10.7 – 21.0)
17.9
(14.2 – 21.6)
RMSSD, ms 35.1
(29.2 – 41.0)
37.1
(32.2 – 42.0)
SDNN, ms 61.2
(54.9 – 67.5)
65.6*
(59.0 – 72.2)
Triangular Index 12.9
(11.9 – 13.9)
13.8
(13.0 – 14.5)
LF-power, ms2 816
(628 – 1004)
919*
(717 – 1122)
HF-power, ms2 460
(325 – 595)
485
(400 – 569)
LFn, ms 62.8
(56.7 – 68.9)
64.5
(60.6 – 68.4)
HFn, ms 29.2
(25.5 – 32.8)
30.0
(27.0 – 33.1)
HF/LF ratio 0.738
(0.507 – 0.970)
0.680
(0.519 – 0.842)
All data expressed as mean (95% confidence interval). *P < 0.05 compared to control (no mask) day, Student's paired t-test.Particle and Fibre Toxicology 2009, 6:8 http://www.particleandfibretoxicology.com/content/6/1/8
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± 340 ms2, P < 0.05) over the 24 hours when subjects wore
the mask. There were no clinically relevant arrhythmias
recorded in any subject (Table 3).
During the 2-hour walk, there was no difference in exer-
cise intensity in the presence or absence of the facemask
(Table 4) although subjects had a lower systolic blood
pressure (114 ± 10 vs 121 ± 11 mmHg; P < 0.01) when
wearing a mask. This was not associated with a change in
diastolic blood pressure, heart rate or in heart rate varia-
bility measurements.
Subjects reported only very minor symptoms (Table 5)
during the study period. The mask was generally well tol-
erated with an average score of 24.8% (95% CI, 16.2 –
33.3%); 0% being completely tolerable and 100% being
intolerable.
Discussion
In this study, we have shown for the first time that a sim-
ple well-tolerated personal intervention to reduce expo-
sure to airborne particulate air pollution leads to a
reduction in systolic blood pressure during exercise and
an increase in heart rate variability. If translated into a sus-
ceptible population, our findings would suggest that
wearing a simple facemask has the potential to reduce the
incidence of acute cardiovascular events in cities with high
levels of air pollution, and could influence the advice
given to patients with chronic cardiovascular diseases.
We tested a range of facemasks that differed widely in
their efficiency as particle filters. In general, those masks
designed to reduce occupational exposure to dusts were
more efficient than those marketed as personal protection
to cyclists and pedestrians in an environmental setting.
The choice of the mask used in this study was influenced
by efficiency and comfort. The chosen mask was very well
tolerated by subjects as demonstrated by the visual ana-
logue score, and was predicted to reduce the exposure to
particulate matter dramatically. When wearing the masks,
the subjects did report slightly greater difficulty breathing
whilst walking although this did not reduce the level of
exercise undertaken by the subjects. This increased resist-
ance to respiration is unlikely to affect the main study
findings since such stresses would be predicted to increase
blood pressure rather than reduce it.
Recent studies have confirmed a link between blood pres-
sure and exposure to air pollution. Population-based
studies have shown increases in both systolic blood pres-
sure and pulse pressure [17,18] with increasing levels of
ambient pollution exposure. Controlled exposure studies
to concentrated ambient particles and ozone have dem-
onstrated an increase in diastolic blood pressure during a
two-hour exposure [12]. Although there were no differ-
ences in blood pressure over the whole 24-hour period,
we observed a marked difference in systolic blood pres-
sure with exercise. In both groups, blood pressure
increased during exercise compared to the 24-hour aver-
age, although this increase was less when wearing a face-
mask. This, in combination with previous controlled
exposure studies [12], suggests that particulate air pollu-
tion may augment exercise-induced increases in blood
pressure, and that the use of a simple facemask can abro-
gate this. Exercise induced increases in systolic blood pres-
sure have been linked to myocardial infarction [19] as
well as stroke [20], and increased blood pressure is an
established major risk factor for the development of both
atherosclerosis and cardiovascular mortality [21,22]. The
reduction in systolic blood pressure seen in this study is
similar to that seen with many antihypertensive agents,
which have been shown to reduce major cardiovascular
events. Therefore we predict that the use of a facemask in
a susceptible population has the potential to reduce the
incidence of acute cardiovascular events as well as myo-
cardial ischaemia [13,23].
Heart rate variability is a measure of the variation in the R-
R interval on the electrocardiogram. A balance of the par-
asympathetic and sympathetic nervous systems controls
the heart rate in order to maintain a constant cardiac out-
put at rest or to respond to increased demands during
exercise. A reduction in heart rate variability occurs in var-
ious pathophysiological conditions including hyperten-
sion [24], heart failure [25] and diabetes mellitus [26],
Table 3: Arrhythmia analysis from 24-hour Holter 
electrocardiograms.
Without Mask With Mask
Pause 0 0
Dropped beat 0 0
Ventricular tachycardia 0 0
Salvo 0 0
Triplet 0 0
Couplet 0 0
Bradycardia (=50 bpm) 71 227
Supraventricular tachycardia 0 0
Bigeminy 57 157
Trigeminy 4 7
"R on T" 0 0
Premature aberrant 3246 4698
Isolated aberrant 18 3
Premature normal 11 17
Maximum heart rate 134
(126 – 143)
128
(120 – 137)
Minimum heart rate 51
(48 – 54)
49
(46 – 53)
Data shown are total number of events recorded in each condition 
over all subjects.
P > 0.05 for all (Wilcoxon matched pairs test). Maximum and 
minimum heart rates shown as mean (95% confidence intervals), P > 
0.05 for both, Student's paired t-test.Particle and Fibre Toxicology 2009, 6:8 http://www.particleandfibretoxicology.com/content/6/1/8
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and predicts cardiovascular outcomes [27]. Previous stud-
ies have demonstrated a reduction in measures of heart
rate variability, particularly the robust and simple time-
domain measurement SDNN following exposure to air
pollution [14,15,28-33]. In our study we report an
increase in overall heart rate variability (SDNN) when
subjects wore a mask, suggesting that wearing a mask can,
at least in part, prevent the adverse effects of air pollution
exposure on heart rate variability.
LF-power also increased with the use of a mask to prevent
exposure to air pollution although interpreting this
change is more challenging. LF-power is associated with
changes in sympathetic tone, and an increase might sug-
gest an increased contribution of the sympathetic nervous
system to basal heart rate control. However, simply wear-
ing the facemask may have had a small effect on the meas-
ures of heart rate variability described. As previously
discussed, subjects did report an increased resistance to
breathing when wearing the facemask that may have
increased subject anxiety. This in turn could have
increased sympathetic nervous system tone and hence
lead to a small increase in LF-power. This is a limitation of
our study, and the use of a sham facemask in a blinded
fashion would have helped minimise the effect of anxiety
on these sensitive outcome measures.
Our study has a number of important public health mes-
sages. First we have demonstrated that exposure to ambi-
ent air pollution has direct and measurable effects on
cardiovascular physiological parameters, even young
healthy individuals habitually exposed to such elevated
levels. Second we have shown that wearing a facemask can
abrogate some of these effects in a short period of time.
Particle traps are increasingly being fitted to new vehicles
to reduce the emissions of particulate matter, both by
mass and number concentrations, and this may well go
some way to offsetting the associated health effects. Cur-
rently, patients with chronic respiratory and cardiovascu-
lar conditions are advised to limit their exposure outdoors
Table 4: Exercise performed and physiological parameters during 2-hour walk.
Without Mask With Mask
Activity Energy expenditure, kcals 340
(314 – 367)
364
(304 – 426)
Energy expenditure, METS 3.33
(3.09 – 3.57)
3.61
(3.12 – 4.10)
Ambulatory blood pressure Systolic blood pressure, mmHg 121
(115 – 127)
114*
(108 – 120)
Diastolic blood pressure, mmHg 81
(75 – 87)
79
(74 – 83)
Mean arterial pressure, mmHg 94
(89 – 99)
90
(86 – 94)
Heart rate, bpm 88
(82 – 94)
91
(85 – 97)
Heart rate variability Data validity, % 99.1 97.8
Average NN interval, ms 594
(562 – 627)
613
(571 – 655)
pNN50, % 3.3
(0.8 – 5.7)
2.1
(-0.1 – 4.4)
RMSSD, ms 17.2
(13.4 – 21.0)
20.0
(15.5 – 24.6)
SDNN, ms 45.8
(36.8 – 54.8)
54.8
(42.5 – 67.0)
Triangular Index 10.7
(9.1 – 12.4)
11.4
(9.4 – 13.3)
LF-power, ms2 313
(170 – 455)
414
(233 – 595)
HF-power, ms2 76.5
(33.6 – 120.0)
116.8
(52.6 – 181.0)
LFn, ms 68.2
(60.9 – 75.5)
67.9
(61.9 – 73.9)
HFn, ms 16.1
(11.9 – 20.3)
16.0
(12.5 – 19.4)
HF/LF ratio 0.259
(0.173 – 0.344)
0.247
(0.180 – 0.314)
All data expressed as mean (95% confidence interval).
*P < 0.01 compared to control (without mask) day, paired Student's t-test.
P > 0.05 for all other parameters compared to control (without mask) day.Particle and Fibre Toxicology 2009, 6:8 http://www.particleandfibretoxicology.com/content/6/1/8
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on days when ambient air pollution levels are high [34-
36]. We have shown that wearing a simple inexpensive
and well-tolerated facemask can provide an alternative
that may lead to reduced cardiovascular morbidity and
mortality. We believe that this intervention now needs to
be tested in patients with pre-existing coronary heart dis-
ease to define its potential role in reducing the burden of
cardiovascular disease in polluted environmental settings.
Our study has a number of important limitations. We
recruited young healthy volunteers rather than those most
susceptible to the effects of air pollution exposure, such as
those with coronary heart disease. Whilst it is likely that
our findings will be transferrable to this population, fur-
ther studies are required to confirm our findings. In addi-
tion, it was not possible to assess accurately the efficacy of
the mask filter when worn by the subjects. Leaks around
the facemask will lead to a reduction in the efficacy of par-
ticle filtration [37,38] and therefore our predicted expo-
sures during application of the facemask are likely to be
an underestimate. However, despite this, we were still able
to demonstrate beneficial cardiovascular effects during
their use.
Conclusion
Air pollution exposure is associated with increased cardi-
ovascular morbidity and mortality, and adverse effects on
the cardiovascular system. We have shown for the first
time that a wearing a facemask appears to abrogate the
adverse effects of air pollution on blood pressure and
heart rate variability. This simple intervention has the
potential to protect susceptible individuals and prevent
cardiovascular events in cities with high concentrations of
ambient air pollution.
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Irritation of the nose 1.00 ± 2.56 1.53 ± 3.78 1.27 ± 3.58 0.67 ± 1.23 1.07 ± 1.91 0.67 ± 1.35 n/s
Unpleasant smell 0.40 ± 0.74 0.93 ± 1.22 1.00 ± 1.69 0.67 ± 1.23 0.60 ± 0.91 0.80 ± 1.15 n/s
Bad taste 0.53 ± 1.13 0.73 ± 0.96 0.60 ± 0.83 0.40 ± 0.74 0.60 ± 1.18 0.93 ± 1.49 n/s
Difficulty walking 12.53 ± 13.24 15.13 ± 11.51 n/s
Perception of pollution 19.80 ± 18.37 11.60 ± 10.44 n/s
All data expressed as mean ± standard deviation. "Difficulty walking" and "Perception of pollution" tested using paired Student's t-tests. All other 
variables tested using 2-way ANOVA with repeated measures including time and mask intervention as variables. P value shown is the effect of the 
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